thumbnail

Federal-state aquaculture drug registration partnership: A success story in the making

Fisheries

By:
, , and

Links

  • The Publications Warehouse does not have links to digital versions of this publication at this time
  • Download citation as: RIS

Abstract

During the past 20 years, aquaculture has grown both as a vital tool for fisheries management and as a viable industry. But now a crisis has arisen from the Food and Drug Administration's (FDA) increased regulation of drug use in aquaculture in response to public concerns about human food safety, human health, and environmental effects. Lack of approved drugs and chemicals has dramatically reduced the effectiveness and increased the cost of fish production for natural resource management agencies. To make badly needed therapeutants available, the FDA is requiring an array of specialized laboratory research studies and clinical field trials. Pharmaceutical manufacturers are reluctant to undertake any major efforts to gain approval of aquaculture drugs because each (i.e., use on one species for one purpose) is estimated to cost a minimum of $3.5 million. Hence, the expenditure is not warranted by the apparent market potential. Only three therapeutants and one anesthetic are currently approved and available to hatchery managers.

Additional Publication Details

Publication type:
Article
Publication Subtype:
Journal Article
Title:
Federal-state aquaculture drug registration partnership: A success story in the making
Series title:
Fisheries
Volume
21
Issue:
5
Year Published:
1996
Language:
English
Publisher:
U.S. Fish and Wildlife Service
Contributing office(s):
Upper Midwest Environmental Sciences Center
Description:
p. 4
Larger Work Type:
Article
Larger Work Subtype:
Journal Article
Larger Work Title:
Fisheries
First page:
4
Number of Pages:
-3